The value of genetic and genomic technologies: workshop summary
Saved in:
| Corporate Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Washington, D.C.
National Academies Press
c2010
|
| Subjects: | |
| Item Description: | "Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy." |
| Physical Description: | xv, 92 p |
| ISBN: | 0309157714 9780309157711 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044844833 | ||
| 003 | DE-604 | ||
| 005 | 20180305 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180305s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 0309157714 |9 0-309-15771-4 | ||
| 020 | |a 9780309157711 |9 978-0-309-15771-1 | ||
| 035 | |a (ZDB-38-ESG)ebr10439396 | ||
| 035 | |a (OCoLC)672515579 | ||
| 035 | |a (DE-599)BVBBV044844833 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 110 | 2 | |a Institute of Medicine (U.S.) |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a The value of genetic and genomic technologies |b workshop summary |c Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2010 | |
| 300 | |a xv, 92 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a "Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy." | ||
| 505 | 8 | |a Includes bibliographical references | |
| 505 | 8 | |a Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks | |
| 505 | 8 | |a "Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page | |
| 650 | 4 | |a Genomics |v Congresses | |
| 650 | 4 | |a Genomics |x Research |v Congresses | |
| 650 | 4 | |a Human chromosome abnormalities |x Diagnosis |v Congresses | |
| 650 | 4 | |a Genetic counseling |v Congresses | |
| 650 | 4 | |a Genetic disorders |x Diagnosis |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Wizemann, Theresa M. |e Sonstige |4 oth | |
| 700 | 1 | |a Berger, Adam C. |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |e Roundtable on Translating Genomic-Based Research for Health |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |e Board on Health Sciences Policy |4 oth | |
| 912 | |a ZDB-38-ESG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030239696 | ||
Record in the Search Index
| _version_ | 1804178355970375680 |
|---|---|
| any_adam_object | |
| author_corporate | Institute of Medicine (U.S.) |
| author_corporate_role | aut |
| author_facet | Institute of Medicine (U.S.) |
| author_sort | Institute of Medicine (U.S.) |
| building | Verbundindex |
| bvnumber | BV044844833 |
| collection | ZDB-38-ESG |
| contents | Includes bibliographical references Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks "Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page |
| ctrlnum | (ZDB-38-ESG)ebr10439396 (OCoLC)672515579 (DE-599)BVBBV044844833 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02271nmm a2200445zc 4500</leader><controlfield tag="001">BV044844833</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180305 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180305s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309157714</subfield><subfield code="9">0-309-15771-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309157711</subfield><subfield code="9">978-0-309-15771-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-ESG)ebr10439396</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)672515579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044844833</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The value of genetic and genomic technologies</subfield><subfield code="b">workshop summary</subfield><subfield code="c">Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xv, 92 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy."</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield><subfield code="x">Research</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human chromosome abnormalities</subfield><subfield code="x">Diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic counseling</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic disorders</subfield><subfield code="x">Diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wizemann, Theresa M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berger, Adam C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="e">Roundtable on Translating Genomic-Based Research for Health</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="e">Board on Health Sciences Policy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-ESG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030239696</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV044844833 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:02:40Z |
| institution | BVB |
| isbn | 0309157714 9780309157711 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030239696 |
| oclc_num | 672515579 |
| open_access_boolean | |
| physical | xv, 92 p |
| psigel | ZDB-38-ESG |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Institute of Medicine (U.S.) Verfasser aut The value of genetic and genomic technologies workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies Washington, D.C. National Academies Press c2010 xv, 92 p txt rdacontent c rdamedia cr rdacarrier "Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy." Includes bibliographical references Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks "Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page Genomics Congresses Genomics Research Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses (DE-588)1071861417 Konferenzschrift gnd-content Wizemann, Theresa M. Sonstige oth Berger, Adam C. Sonstige oth Institute of Medicine (U.S.) Roundtable on Translating Genomic-Based Research for Health oth Institute of Medicine (U.S.) Board on Health Sciences Policy oth |
| spellingShingle | The value of genetic and genomic technologies workshop summary Includes bibliographical references Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks "Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page Genomics Congresses Genomics Research Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses |
| subject_GND | (DE-588)1071861417 |
| title | The value of genetic and genomic technologies workshop summary |
| title_auth | The value of genetic and genomic technologies workshop summary |
| title_exact_search | The value of genetic and genomic technologies workshop summary |
| title_full | The value of genetic and genomic technologies workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies |
| title_fullStr | The value of genetic and genomic technologies workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies |
| title_full_unstemmed | The value of genetic and genomic technologies workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies |
| title_short | The value of genetic and genomic technologies |
| title_sort | the value of genetic and genomic technologies workshop summary |
| title_sub | workshop summary |
| topic | Genomics Congresses Genomics Research Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses |
| topic_facet | Genomics Congresses Genomics Research Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses Konferenzschrift |
| work_keys_str_mv | AT instituteofmedicineus thevalueofgeneticandgenomictechnologiesworkshopsummary AT wizemanntheresam thevalueofgeneticandgenomictechnologiesworkshopsummary AT bergeradamc thevalueofgeneticandgenomictechnologiesworkshopsummary |